Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Connection

Search Results to Myron J Levin

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Levin, Myron

Item TypeName
Academic Article Phenotypic and functional characterization of ex vivo T cell responses to the live attenuated herpes zoster vaccine.
Academic Article Evaluation of the cost-effectiveness in the United States of a vaccine to prevent herpes zoster and postherpetic neuralgia in older adults.
Academic Article Cost-effectiveness of herpes zoster vaccine: flawed assumptions regarding efficacy against postherpetic neuralgia.
Academic Article Varicella-zoster virus-specific immune responses in elderly recipients of a herpes zoster vaccine.
Academic Article Varicella vaccine in the United States: a decade of prevention and the way forward.
Academic Article Immune response to a refrigerator-stable zoster vaccine.
Academic Article Safety, tolerability, and immunogenicity of zoster vaccine in subjects with a history of herpes zoster.
Academic Article Safety of herpes zoster vaccine in the shingles prevention study: a randomized trial.
Academic Article Prevention strategies for herpes zoster and post-herpetic neuralgia.
Academic Article Effect of a zoster vaccine on herpes zoster-related interference with functional status and health-related quality-of-life measures in older adults.
Academic Article Persistence of the efficacy of zoster vaccine in the shingles prevention study and the short-term persistence substudy.
Academic Article Varicella zoster virus-specific immune responses to a herpes zoster vaccine in elderly recipients with major depression and the impact of antidepressant medications.
Academic Article The prevention and management of herpes zoster.
Academic Article Vaccination against Herpes Zoster and Postherpetic Neuralgia.
Academic Article Varicella-zoster virus-specific immune responses to herpes zoster in elderly participants in a trial of a clinically effective zoster vaccine.
Academic Article The impact of herpes zoster and postherpetic neuralgia on health-related quality of life: a prospective study.
Academic Article Association between prodromal pain and the severity of acute herpes zoster and utilization of health care resources.
Academic Article Efficacy, safety, and tolerability of herpes zoster vaccine in persons aged 50-59 years.
Academic Article Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults =60 years of age.
Academic Article Immune senescence and vaccines to prevent herpes zoster in older persons.
Concept Herpes Zoster Vaccine
Academic Article Safety of zoster vaccine in elderly adults following documented herpes zoster.
Academic Article Varicella-zoster virus-specific antibody responses in 50-59-year-old recipients of zoster vaccine.
Academic Article Vaccination against herpes zoster in developed countries: state of the evidence.
Academic Article Broadly reactive human CD8 T cells that recognize an epitope conserved between VZV, HSV and EBV.
Academic Article Long-term persistence of zoster vaccine efficacy.
Academic Article Efficacy of an adjuvanted herpes zoster subunit vaccine in older adults.
Academic Article Cellular and Humoral Responses to a Second Dose of Herpes Zoster Vaccine Administered 10 Years After the First Dose Among Older Adults.
Academic Article Immune response and reactogenicity of intradermal administration versus subcutaneous administration of varicella-zoster virus vaccine: an exploratory, randomised, partly blinded trial.
Academic Article Efficacy of the Herpes Zoster Subunit Vaccine in Adults 70 Years of Age or Older.
Academic Article Shedding Light on Shingles: The Power of Prevention.
Academic Article Varicella-Zoster Virus-Specific Cellular Immune Responses to the Live Attenuated Zoster Vaccine in Young and Older Adults.
Academic Article Immunogenicity and safety of zoster vaccine live administered with quadrivalent influenza virus vaccine.
Academic Article Studies with herpes zoster vaccines in immune compromised patients.
Academic Article Varicella-Zoster Virus DNA in Blood After Administration of Herpes Zoster Vaccine.
Academic Article Complications of herpes zoster in immunocompetent older adults: Incidence in vaccine and placebo groups in two large phase 3 trials.
Academic Article Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.
Academic Article Low Rates of Vaccination for Herpes Zoster in Older People Living With HIV.
Academic Article Quality of Life Impact of an Adjuvanted Recombinant Zoster Vaccine in Adults Aged 50 Years and Older.
Academic Article Th1 memory differentiates recombinant from live herpes zoster vaccines.
Academic Article Persistence of Varicella-Zoster Virus Cell-Mediated Immunity After the Administration of a Second Dose of Live Herpes Zoster Vaccine.
Academic Article Herpes Zoster and Herpes Zoster Vaccine Rates Among Adults Living With and Without HIV in the Veterans Aging Cohort Study.
Academic Article Comparative Immune Responses to Licensed Herpes Zoster Vaccines.
Academic Article The Impact of Reactogenicity After the First Dose of Recombinant Zoster Vaccine on the Physical Functioning and Quality of Life of Older Adults: An Open-Label, Phase III Trial.
Academic Article Herpes Zoster Vaccines.
Academic Article Immune responses to zoster vaccines.
Academic Article Understanding the immunology of Shingrix, a recombinant glycoprotein E adjuvanted herpes zoster vaccine.
Academic Article The Effect of Age on the Immunogenicity of the Live Attenuated Zoster Vaccine Is Predicted by Baseline Regulatory T Cells and Varicella-Zoster Virus-Specific T Cell Immunity.
Academic Article Evaluation of two frailty indices, with practical application in a vaccine clinical trial.
Academic Article Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials.
Academic Article Adjuvanted Recombinant Glycoprotein E Herpes Zoster Vaccine.
Academic Article Recurrent herpes zoster in the Shingles Prevention Study: Are second episodes caused by the same varicella-zoster virus strain?
Academic Article Herpes Zoster and Its Prevention by Vaccination.
Academic Article Post hoc analysis of reactogenicity trends between dose 1 and dose 2 of the adjuvanted recombinant zoster vaccine in two parallel randomized trials.
Academic Article Impact of Reactogenicity After Two Doses of Recombinant Zoster Vaccine Upon Physical Functioning and Quality of Life: An Open Phase III Trial in Older Adults.
Academic Article Efficacy and serious adverse events profile of the adjuvanted recombinant zoster vaccine in adults with pre-existing potential immune-mediated diseases: a pooled post hoc analysis on two parallel randomized trials.
Academic Article Recombinant Zoster Vaccine Is Efficacious and Safe in Frail Individuals.
Academic Article Vaccines for older adults.
Academic Article Comparative Antibody Responses to the Live-Attenuated and Recombinant Herpes Zoster Vaccines.
Academic Article Association Between Immunogenicity and Reactogenicity: A Post Hoc Analysis of 2 Phase 3 Studies With the Adjuvanted Recombinant Zoster Vaccine.
Academic Article Humoral and cellular immune responses to recombinant herpes zoster vaccine in patients with chronic lymphocytic leukemia and monoclonal B cell lymphocytosis.
Academic Article Cell-Mediated Immune Responses After Administration of the Live or the Recombinant Zoster Vaccine: 5-Year Persistence.
Academic Article Immune Responses to Varicella-Zoster Virus Vaccines.
Academic Article Predictors of 5-Year Persistence of Antibody Responses to Zoster Vaccines.
Academic Article Recruitment of naive CD4+ T cells by the recombinant zoster vaccine correlates with persistent immunity.

Search Criteria
  • Herpes Zoster Vaccine

Copyright © 2024 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)